A.B. Gottlieb
Icahn School of Medicine at Mount Sinai(US)
Publications by Year
Research Areas
Psoriasis: Treatment and Pathogenesis, Spondyloarthritis Studies and Treatments, Rheumatoid Arthritis Research and Therapies, Autoimmune and Inflammatory Disorders Research, Health Systems, Economic Evaluations, Quality of Life
Most-Cited Works
- → Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial(2001)904 cited
- → Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate‐to‐severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2)(2015)472 cited
- → Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: Results of a pilot, multicenter, multiple-dose, placebo-controlled study(2000)129 cited
- → Ixekizumab treatment improves fingernail psoriasis in patients with moderate‐to‐severe psoriasis: results from the randomized, controlled and open‐label phases of UNCOVER‐3(2016)82 cited
- Long-term safety and efficacy of etanercept in patients with psoriasis: an open-label study.(2010)
- → Angiotensin-converting enzyme inhibitors as possible exacerbating drugs in psoriasis(1993)44 cited
- → Etanercept therapy in patients with autoimmunity and hepatitis C(2003)43 cited
- → Ischaemic lacunae in the spinal cord of arteriosclerotic subjects.(1970)30 cited
- → OP0158 Ustekinumab in patients with active psoriatic arthritis: Results of the phase 3, multicenter, double-blind, placebo-controlled psummit I study(2012)21 cited
- → LB0001 BIMEKIZUMAB IN BDMARD-NAIVE PATIENTS WITH PSORIATIC ARTHRITIS: 24-WEEK EFFICACY & SAFETY FROM BE OPTIMAL, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED, ACTIVE REFERENCE STUDY(2022)7 cited